The Preeclampsia Registry is entering a higher level of research impact with the announcement of a new collaboration with Predictive Laboratories, Inc; a biotechnology company based out of Salt Lake City, Utah. Through this valuable partnership, we will launch a new study to request DNA samples and medical records from more than 2,500 registry participants with the hope of developing a test for early detection of women that are at risk for preeclampsia. The samples, records and sequencing data will eventually be available to other researchers.
Keep a close eye on your email for ways that you can help with this research.
_levels_detect_early_preeclampsia1746032701.png)